Amplimmune
A company developing immune-based biologics for the treatment of cancer, autoimmunity, transplantation and infectious diseases
1
Funding Rounds
$20.0m
Money raised
Funding series
Funding Series Analysis
The company Amplimmune has raised a total of $20m in funding over 1 rounds.
Key Insights:
- Amplimmune Series A round: $20m
Amplimmune Series A round
$20m
Industries
Amplimmune is active in the following industries: